Atlas Trials

Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease

Clinical trial NCT04235205 · COMPLETED

Trial details

NCT number
NCT04235205
Sponsor
Yokohama City University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Start date
2020-01-29
Primary completion
2021-07-21
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.